Rethinking hepatitis C viral kinetics: Insights into host-virus interactions in 'difficult-to-treat' groups and implications for novel treatment approaches

J Hepatol. 2005 Nov;43(5):748-50. doi: 10.1016/j.jhep.2005.08.001. Epub 2005 Aug 24.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Clinical Trials as Topic
  • Hepacivirus / genetics
  • Hepacivirus / metabolism*
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Polyethylene Glycols / therapeutic use
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Ribavirin / therapeutic use
  • Treatment Outcome
  • Viral Load

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a